Life Healthcare Group Holdings Limited

JSE:LHC Stock Report

Market Cap: R23.6b

Life Healthcare Group Holdings Valuation

Is LHC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LHC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: LHC (ZAR16.37) is trading above our estimate of fair value (ZAR4.63)

Significantly Below Fair Value: LHC is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for LHC?

Key metric: As LHC is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for LHC. This is calculated by dividing LHC's market cap by their current earnings.
What is LHC's PE Ratio?
PE Ratio11.9x
EarningsR1.99b
Market CapR23.61b

Price to Earnings Ratio vs Peers

How does LHC's PE Ratio compare to its peers?

The above table shows the PE ratio for LHC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average40.2x
NTC Netcare
13.1x16.9%R18.5b
JLHL Jupiter Life Line Hospitals
55.4x18.6%₹102.5b
BSL Raffles Medical Group
25.5x12.2%S$1.6b
AKT Akdital
66.7x45.7%د.م14.7b
LHC Life Healthcare Group Holdings
11.9x7.0%R23.6b

Price-To-Earnings vs Peers: LHC is good value based on its Price-To-Earnings Ratio (11.9x) compared to the peer average (40.2x).

Price to Earnings Ratio vs Industry

How does LHC's PE Ratio compare vs other companies in the Global Healthcare Industry?

12 CompaniesPrice / EarningsEstimated GrowthMarket Cap
LHC 11.9xIndustry Avg. 20.7xNo. of Companies69PE01632486480+
12 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: LHC is good value based on its Price-To-Earnings Ratio (11.9x) compared to the Global Healthcare industry average (20.7x).

Price to Earnings Ratio vs Fair Ratio

What is LHC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LHC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.9x
Fair PE Ratio13.7x

Price-To-Earnings vs Fair Ratio: LHC is good value based on its Price-To-Earnings Ratio (11.9x) compared to the estimated Fair Price-To-Earnings Ratio (13.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LHC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentR16.37
R16.03
-2.1%
16.0%R18.80R11.80n/a6
Dec ’25R16.68
R15.32
-8.2%
15.1%R18.80R11.80n/a6
Nov ’25R16.14
R13.12
-18.7%
7.5%R14.50R11.80n/a6
Oct ’25R16.60
R13.12
-21.0%
7.5%R14.50R11.80n/a6
Sep ’25R14.37
R13.12
-8.7%
7.5%R14.50R11.80n/a6
Aug ’25R13.33
R13.10
-1.7%
7.0%R14.50R11.80n/a7
Jul ’25R12.93
R13.66
+5.7%
11.8%R16.90R11.80n/a7
Jun ’25R11.07
R16.61
+50.0%
20.6%R21.50R12.00n/a6
May ’25R10.76
R18.12
+68.4%
13.6%R21.50R13.63n/a7
Apr ’25R17.19
R19.18
+11.6%
9.4%R21.50R16.33n/a7
Mar ’25R17.60
R20.02
+13.7%
13.8%R24.40R16.33n/a7
Feb ’25R17.98
R20.02
+11.3%
13.8%R24.40R16.33n/a7
Jan ’25R18.37
R20.13
+9.6%
13.7%R24.40R16.33n/a7
Dec ’24R18.05
R21.36
+18.4%
12.5%R24.40R16.90R16.687
Nov ’24R18.75
R22.28
+18.8%
8.1%R24.40R20.05R16.147
Oct ’24R20.26
R21.95
+8.3%
7.5%R24.40R20.05R16.607
Sep ’24R21.45
R21.54
+0.4%
6.5%R24.00R20.05R14.376
Aug ’24R20.80
R21.54
+3.6%
6.5%R24.00R20.05R13.336
Jul ’24R20.55
R20.93
+1.8%
8.0%R24.00R18.70R12.936
Jun ’24R19.15
R20.42
+6.6%
8.2%R24.00R18.70R11.076
May ’24R20.74
R20.18
-2.7%
5.8%R22.50R18.70R10.766
Apr ’24R19.29
R20.17
+4.5%
5.8%R22.50R18.70R17.196
Mar ’24R19.69
R20.91
+6.2%
10.1%R25.34R18.70R17.607
Feb ’24R17.00
R21.17
+24.5%
10.1%R25.50R18.70R17.987
Jan ’24R16.88
R22.43
+32.9%
10.5%R26.00R19.50R18.377
Dec ’23R16.55
R22.43
+35.5%
10.5%R26.00R19.50R18.057

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 00:08
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Life Healthcare Group Holdings Limited is covered by 17 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rendani MagalelaAbsa Bank Limited
Sean UngererArqaam Capital Research Offshore S.A.L.
Simon MatherBarclays